Outlook Therapeutics Secures $31.8 Million in Unsecured Convertible Promissory Note: A Game-Changing Move in the World of Forex Trading

Outlook Therapeutics® Enters Definitive Agreement for $31.8 Million Unsecured Convertible Promissory Notes Financing ISELIN, N.J., Dec. 23, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a leading biopharmaceutical company focused on developing and commercializing ophthalmic products for the treatment of retinal diseases, announced today that it has entered into a Securities Purchase Agreement (SPA)…

Read More

Breaking News: Connexa Sports Technologies Inc. Receives Notice from NASDAQ for Late Filing of Quarterly Report

Connexa Sports Technologies Inc. Faces Compliance Issue with Nasdaq Baltimore, Dec. 23, 2022 (GLOBE NEWSWIRE) Connexa Sports Technologies Inc. (NASDAQ: CNXA) recently announced that it has received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) on December 20, 2022, informing the Company that it is not in compliance with the periodic filing requirements for…

Read More

Breaking News: Intercept Reapplies for FDA Approval of Obeticholic Acid for Liver Fibrosis in NASH Patients

Intercept Resubmits New Drug Application to U.S. FDA for Obeticholic Acid in Patients with Liver Fibrosis NDA supported by robust NASH clinical development program Two positive interim analyses from the Phase 3 REGENERATE study NDA includes detailed safety analysis of 2,477 patients with nearly 1,000 patients on study drug for 4 years MORRISTOWN, N.J., Dec….

Read More

Calling All Wine Lovers: Don’t Miss Out on Your Chance to Join the Class Action Lawsuit Against Vintage Wine Estates Inc. – Act Fast Before January 13, 2023 with Portnoy Law Firm!

Attention Vintage Wine Estates, Inc. Investors! Last Days to Actively Participate in the Class Action Lawsuit! Don’t Miss Out on Your Chance to Recover Your Losses! Hey there fellow Vintage Wine Estates, Inc. investors! Have you heard the latest news? The Portnoy Law Firm has filed a class action lawsuit on behalf of investors like…

Read More

Get Ready to Geek Out: Applied Molecular Transport Drops Exciting Phase 2 Results for AMT-101 in Ulcerative Colitis Patients!

Welcome to the Blog Post! Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial Exciting News for Patients with Chronic Pouchitis Hey there, fellow health enthusiasts! Have you heard the latest buzz in the medical world? Applied Molecular Transport (AMT) has just released some thrilling updates from their Phase 2 clinical trial…

Read More

Discover the Latest Distributions from PIMCO Canada Corp: Monthly and Annual Updates for PIMCO Canada Exchange-Traded Series

Embracing Change: PIMCO Canada Corp. Announces Monthly and Annual Distributions A New Chapter Begins Change is inevitable in life, and when it comes to financial matters, adapting to change is essential for growth and success. PIMCO Canada Corp. has recently announced the December and annual cash distributions for the ETF series of the PIMCO Canada…

Read More